Fig. S2. Wireframes depicting shape changes (in lateral view) along the PC axes shown in
as estimated from the PCA of 24 facial landmarks. The black wireframes represent the overall mean shape of the entire dataset computed from the facial landmarks; Gray wireframes depict the shape changes along the PC axes from the negative to the positive scores. PC1 captures changes mainly in the anterior-posterior dimension, showing a retraction and extension of the snout from the negative to the positive end. PC2 captures changes in the lateral aspects of the facial skeleton, marked by medio-lateral variation in the infraorbital hiatus. Fig. 4B as estimated from the PCA of cranial vault landmarks. Black wireframes represent the overall mean shape of the entire dataset computed from the cranial vault landmarks; Gray wireframes depict the shape changes along the PC axes from the negative to the positive scores. Shape changes along PC1 related to a more globular vs. elongated cranial vault, and PC2 captures changes in the anterior-posterior dimension of the cranial vault. Fig. 4C as estimated from the PCA of basicranium landmarks. Black wireframes represent the overall mean shape of the entire dataset computed from the basicranium landmarks; Gray wireframes depict the shape changes from the negative to the positive scores along the respective PC axes. PC1 captures changes in the medio-lateral and anterio-posterior dimension, whereas PC2 relates to changes in the posterior aspect of the basicranium. separates a subset of 20μg/g SAG-treated and 40 μg/g SAG-treated euploid mice (marked by the gray shaded area) from the remaining SAG-and vehicle-treated euploid animals and from the trisomic groups. The SAG-treated trisomic mice show some variation along PC1, extending towards the affected SAG-treated euploids on the positive end of PC1 (marked by the smaller gray area). Trisomic and euploid mice separate somewhat along PC2 but these differences are masked by the strong morphological affects of the agonist on craniofacial morphology. PC2 mainly captures the within-group variation among the SAG mice, distinguishing between the lower and higher dosed specimens and subtle variation between the trisomic groups and unaffected and vehicle euploid mice. Regression analysis showing clear differences in shape and size between the euploid and trisomic groups. B) Regression analysis that includes the 40μg/g SAG-treated euploid mice confirming a distinct difference between the euploid and trisomic groups but also showing that the 40μg/g SAGtreated mice are distinct in shape and smaller in size than the other euploid mice. 
Fig. S3. Wireframes depicting shape changes (dorsal view) along the PC axes shown in

Fig. S4. Wireframes illustrating shape changes of the basicranium (ventral view) along the PC axes shown in
